Back to Clinical Trials
N/ARecruiting

CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations

Sponsored by Capsicure, LLC

About this study

CAMP RWE Trial: A Multicenter hybrid platform trial comparing the effects of a prospective cohort treated with a tri-layer amnion graft or a single layer amnion graft to a coarsened exact matched retrospective control cohort of patients with hard-to-heal DFUs and VLUs

A multicenter hybrid platform trial comparing the effects of a prospective cohort treated with a tri layer amnion graft or a single layer amnion graft to a coarsened exact matched retrospective control cohort of patients with hard-to-heal DFUs and VLUs Hybrid prospective platform 2 arm, comparative, randomized multicenter study with a CSM matched retrospective control group Interventional comparative study * IP 1: BioLab Membrane Wrap Lite * IP2: BioLab Tri-Membrane Wrap Standard of care: Debridement, maintenance of proper moisture balance, reduction in bacterial burden, offloading and multilayer compression. Patients with nonhealing venous leg ulcerations or diabetic foot ulcers of at least 4-weeks duration that have failed to show 50% PAR with SOC therapies Patients receiving SOC the…

Where this study is enrolling (7)

Show all 7 locations
Who can participate

Inclusion criteria

  • ✓1. Male or female 18 years of age and older
  • ✓2. 2\. Subjects having a non-healing venous leg ulcer or diabetic foot ulcer of \>4 weeks duration and visible signs of healing objectively, less than 50% reduction in wound size in the last 4 weeks
  • ✓3. Subjects' wound size is minimum of 2 cm2 and maximum of 25cm2
  • ✓4. If the subject has more than one eligible wound the largest wound will be selected (the index wound)
  • ✓5. Subject is able and willing to follow the protocol requirements
  • ✓6. Subject has signed informed consent

Exclusion criteria

  • ✕1. Inability to adhere to the study protocol or study visit schedule
  • ✕2. Pregnancy
  • ✕3. Child-bearing potential without appropriate contraception
  • ✕4. Lactation
  • ✕5. Treatment of the wound with engineered tissue or other scaffold materials within 30 days preceding the first treatment visit.
  • ✕6. Visible signs of improvement in the four weeks before randomisation (defined objectively as a 50% reduction in surface area in the four weeks before enrolment)
  • ✕7. The subject has other concurrent conditions that in the opinion of the investigator may compromise subject safety
  • ✕8. Known contraindications to the use of amniotic tissue grafts
  • ✕9. The index ulcer shows clinical signs and symptoms of wound infection needing treatment with local or systemic antimicrobials or antibiotics

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.